| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |